Autopsy report · NCT03520153

Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome

“The principal investigator is leaving Yale University and will not be continuing the work at her new institution.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Yale University

Sponsor type

University, hospital or other

Conditions

McCune-Albright Syndrome; Fibrous Dysplasia; Intraductal Papillary Mucinous Neoplasm; Diabetes Mellitus

Interventions

Hyperinsulinemic Euglycemic Clamp and 2H20; Hyperglycemic Clamp; Oral Glucose Tolerance Test

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Sciatic Block in Contralateral Limb Phantom and Residual Limb Pain
  “Principal investigator is leaving the university.” (74% match in meaning)
• Wearable Auscultation Device Validation in Children
  “The Principal Investigator is departing from the study site.” (65% match in meaning)
• Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer
  “Resignation of Principal Investigator” (64% match in meaning)
• Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma
  “The original principal Investigator left the institution.” (63% match in meaning)
• Brain Function in Depression and Insulin Resistance
  “Principal Investigator Left University” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.